Lex Fridman Podcast cover image

#263 – John Abramson: Big Pharma

Lex Fridman Podcast

00:00

Pharmaceutical Influence and Public Health

This chapter explores the controversial dynamics between pharmaceutical companies and regulatory agencies, focusing on the 'revolving door' phenomenon and conflicts of interest. It particularly critiques the FDA's approval of the Alzheimer's drug Adjahelm, raising concerns about the impact of financial ties on regulatory decisions. The discussion advocates for stricter regulations, emphasizing the need for a shift in funding from drug research to preventive health measures to improve public health outcomes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app